Completed
Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma
NCT01665768
- Conditions
- CD20+, B-cell Lymphomas, Gray Zone Lymphoma, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States